| Year |
Citation |
Score |
| 2024 |
Wood N, Straw S, Cheng CW, Hirata Y, Pereira MG, Gallagher H, Egginton S, Ogawa W, Wheatcroft SB, Witte KK, Roberts LD, Bowen TS. Sodium-glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction. European Journal of Heart Failure. PMID 38468429 DOI: 10.1002/ejhf.3192 |
0.307 |
|
| 2024 |
Mullens W, Dauw J, Gustafsson F, Mebazaa A, Steffel J, Witte KK, Delgado V, Linde C, Vernooy K, Anker SD, Chioncel O, Milicic D, Hasenfuß G, Ponikowski P, Stephan von Bardeleben R, et al. Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC). European Journal of Heart Failure. PMID 38269474 DOI: 10.1002/ejhf.3150 |
0.321 |
|
| 2023 |
Safdar NZ, Kamalathasan S, Gupta A, Wren J, Bird R, Papp D, Latto R, Ahmed A, Palin V, Gierula J, Witte KK, Straw S. Outcomes following cardiac resynchronisation therapy in older people. Age and Ageing. 52. PMID 38035797 DOI: 10.1093/ageing/afad222 |
0.367 |
|
| 2023 |
Straw S, Witte KK. Remote monitoring in heart failure: it's the data you collect what you do with them. Heart (British Cardiac Society). PMID 36702540 DOI: 10.1136/heartjnl-2022-322137 |
0.365 |
|
| 2022 |
Berger M, Kumowski N, Straw S, Verket M, Marx N, Witte KK, Schütt K. Clinical implications and risk factors for QRS prolongation over time in heart failure patients. Clinical Research in Cardiology : Official Journal of the German Cardiac Society. PMID 36378295 DOI: 10.1007/s00392-022-02122-y |
0.398 |
|
| 2022 |
Sundaram V, Zakeri R, Witte KK, Quint JK. Development of algorithms for determining heart failure with reduced and preserved ejection fraction using nationwide electronic healthcare records in the UK. Open Heart. 9. PMID 36332942 DOI: 10.1136/openhrt-2022-002142 |
0.34 |
|
| 2022 |
Straw S, Napp A, Witte KK. 'Acute Heart Failure': Should We Abandon the Term Altogether? Current Heart Failure Reports. PMID 36166184 DOI: 10.1007/s11897-022-00576-9 |
0.426 |
|
| 2022 |
Witte KK, Wachter R, Senni M, Belohlavek J, Straburzynska-Migaj E, Fonseca C, Lonn E, Noè A, Schwende H, Butylin D, Chiang Y, Pascual-Figal D. Influence of diabetes on sacubitril/valsartan titration and clinical outcomes in patients hospitalized for heart failure. Esc Heart Failure. PMID 36125177 DOI: 10.1002/ehf2.14166 |
0.341 |
|
| 2022 |
Palin V, Drozd M, Garland E, Malik A, Straw S, McGinlay M, Simms A, Gatenby VK, Sengupta A, Levelt E, Witte KK, Kearney MT, Cubbon RM. Reduction of heart failure guideline-directed medication during hospitalization: prevalence, risk factors, and outcomes. Esc Heart Failure. PMID 35796239 DOI: 10.1002/ehf2.14051 |
0.307 |
|
| 2022 |
Gierula J, Cole CA, Drozd M, Lowry JE, Straw S, Slater TA, Paton MF, Byrom RJ, Garland E, Halliday G, Winsor S, Lyall GK, Birch K, McGinlay M, Sunley E, ... ... Witte KK, et al. Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure. Esc Heart Failure. PMID 35790085 DOI: 10.1002/ehf2.14004 |
0.462 |
|
| 2022 |
Straw S, Cole CA, McGinlay M, Drozd M, Slater TA, Lowry JE, Paton MF, Levelt E, Cubbon RM, Kearney MT, Witte KK, Gierula J. Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction. Clinical Research in Cardiology : Official Journal of the German Cardiac Society. PMID 35781605 DOI: 10.1007/s00392-022-02053-8 |
0.39 |
|
| 2022 |
Thiele K, Cornelissen A, Florescu R, Kneizeh K, Brandenburg VM, Witte K, Marx N, Schuh A, Stöhr R. The Role of Vitamin D as an Independent Predicting Marker for One-Year Mortality in Patients with Acute Heart Failure. Journal of Clinical Medicine. 11. PMID 35628860 DOI: 10.3390/jcm11102733 |
0.34 |
|
| 2022 |
Straw S, Gierula J, Witte KK. Designing clinical trials in heart failure with preserved ejection fraction: quality over quantity? European Journal of Heart Failure. PMID 35445788 DOI: 10.1002/ejhf.2510 |
0.338 |
|
| 2022 |
Malik A, Garland E, Drozd M, Palin V, Giannoudi M, Straw S, Jex N, Walker AM, Gierula J, Paton M, Witte KK, Kearney MT, Levelt E, Cubbon RM. Diabetes mellitus and the causes of hospitalisation in people with heart failure. Diabetes & Vascular Disease Research. 19: 14791641211073943. PMID 35236158 DOI: 10.1177/14791641211073943 |
0.325 |
|
| 2022 |
Straw S, Sengupta A, Gantenby VK, Schlosshan D, Ferrara A, Witte KK. An enormous right atrial myxoma highlights the role of echocardiography in heart failure pathways: a case report. European Heart Journal. Case Reports. 6: ytac042. PMID 35233493 DOI: 10.1093/ehjcr/ytac042 |
0.358 |
|
| 2022 |
Claxton L, Simmonds M, Beresford L, Cubbon R, Dayer M, Gottlieb SS, Hartshorne-Evans N, Kilroy B, Llewellyn A, Rothery C, Sharif S, Tierney JF, Witte KK, Wright K, Stewart LA. Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation. Health Technology Assessment (Winchester, England). 26: 1-128. PMID 35076012 DOI: 10.3310/KVOU6959 |
0.356 |
|
| 2021 |
Paton MF, Gierula J, Lowry JE, Cairns DA, Bose Rosling K, Cole CA, McGinlay M, Straw S, Byrom R, Cubbon RM, Kearney MT, Witte KK. Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trial. Plos One. 16: e0259450. PMID 34898655 DOI: 10.1371/journal.pone.0259450 |
0.395 |
|
| 2021 |
Straw S, Gierula J, Witte KK. Heart rate, exercise capacity, and the force-frequency relationship in chronic heart failure. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 34849743 DOI: 10.1093/europace/euab276 |
0.393 |
|
| 2021 |
Witte KK, Goldberg SL, Kaye D, Starling R. Reply to 'Benefits of transvenous mitral annuloplasty in heart failure with lower degrees of functional mitral regurgitation'. European Journal of Heart Failure. 23: 1985-1986. PMID 34655284 DOI: 10.1002/ejhf.2367 |
0.42 |
|
| 2021 |
Thirunavukarasu S, Jex N, Chowdhary A, Ul Hassan I, Straw S, Craven TPC, Gorecka M, Broadbent D, Swoboda P, Witte KK, Cubbon RM, Xue H, Kellman P, Greenwood JP, Plein S, et al. Empagliflozin Treatment is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes. Diabetes. PMID 34610982 DOI: 10.2337/db21-0270 |
0.32 |
|
| 2021 |
McGinlay M, Straw S, Byrom-Goulthorp R, Relton SD, Gierula J, Cubbon RM, Kearney MT, Witte KK. Suboptimal Dosing of β-Blockers in Chronic Heart Failure: A Missed Opportunity? The Journal of Cardiovascular Nursing. PMID 34321430 DOI: 10.1097/JCN.0000000000000847 |
0.35 |
|
| 2021 |
Straw S, McGinlay M, Gierula J, Lowry JE, Paton MF, Cole C, Drozd M, Koshy AO, Mullens W, Cubbon RM, Kearney MT, Witte KK. Impact of QRS duration on left ventricular remodelling and survival in patients with heart failure. Journal of Cardiovascular Medicine (Hagerstown, Md.). PMID 34261079 DOI: 10.2459/JCM.0000000000001231 |
0.444 |
|
| 2021 |
McGinlay M, Straw S, Jagger J, Nouri B, Gierula J, Witte KK. Impact of the COVID-19 pandemic on the management of chronic heart failure. Reviews in Cardiovascular Medicine. 22: 271-276. PMID 34258895 DOI: 10.31083/j.rcm2202034 |
0.384 |
|
| 2021 |
Mullens W, Auricchio A, Martens P, Witte K, Cowie MR, Delgado V, Dickstein K, Linde C, Vernooy K, Leyva F, Bauersachs J, Israel CW, Lund LH, Donal E, Boriani G, et al. Optimized implementation of cardiac resynchronization therapy: a call for action for referral and optimization of care. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 34037728 DOI: 10.1093/europace/euaa411 |
0.405 |
|
| 2021 |
Saunderson CED, Paton MF, Brown LAE, Gierula J, Chew PG, Das A, Sengupta A, Craven TP, Chowdhary A, Koshy A, White H, Levelt E, Dall'Armellina E, Garg P, Witte KK, et al. Detrimental Immediate and Medium-Term Clinical Effects of Right Ventricular Pacing in Patients With Myocardial Fibrosis. Circulation. Cardiovascular Imaging. CIRCIMAGING120012256. PMID 34000818 DOI: 10.1161/CIRCIMAGING.120.012256 |
0.374 |
|
| 2021 |
Straw S, McGinlay M, Witte KK. Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction. Open Heart. 8. PMID 33653703 DOI: 10.1136/openhrt-2021-001585 |
0.434 |
|
| 2021 |
Gierula J, Paton MF, Witte KK. Advances in cardiac resynchronization and implantable cardioverter/defibrillator therapy: Medtronic Cobalt and Crome. Future Cardiology. 17: 609-618. PMID 33635121 DOI: 10.2217/fca-2020-0117 |
0.335 |
|
| 2021 |
Kearney J, Drozd M, Walker AM, Slater TA, Straw S, Gierula J, Paton M, Lowry J, Cole C, Witte KK, Cubbon RM, Kearney MT. Diabetes, gender and deterioration in estimated glomerular filtration rate in patients with chronic heart failure: Ten-year prospective cohort study. Diabetes & Vascular Disease Research. 18: 1479164120984433. PMID 33588611 DOI: 10.1177/1479164120984433 |
0.369 |
|
| 2021 |
Mullens W, Auricchio A, Martens P, Witte K, Cowie MR, Delgado V, Dickstein K, Linde C, Vernooy K, Leyva F, Bauersachs J, Israel CW, Lund L, Donal E, Boriani G, et al. Optimized Implementation of cardiac resynchronization therapy - a call for action for referral and optimization of care. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. PMID 33544835 DOI: 10.1093/europace/euab035 |
0.315 |
|
| 2020 |
Gierula J, Lowry JE, Paton MF, Cole CA, Byrom R, Koshy AA, Chumun H, Kearney LC, Straw S, Bowen TS, Cubbon RM, Keenan AM, Stocken DD, Kearney MT, Witte KK. Response by Gierula et al to Letter Regarding Article, "Personalized Rate-Response Programming Improves Exercise Tolerance After 6 Months in People With Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study". Circulation. 142: e319-e320. PMID 33166218 DOI: 10.1161/CIRCULATIONAHA.120.050610 |
0.306 |
|
| 2020 |
Drozd M, Relton SD, Walker AMN, Slater TA, Gierula J, Paton MF, Lowry J, Straw S, Koshy A, McGinlay M, Simms AD, Gatenby VK, Sapsford RJ, Witte KK, Kearney MT, et al. Association of heart failure and its comorbidities with loss of life expectancy. Heart (British Cardiac Society). PMID 33153996 DOI: 10.1136/heartjnl-2020-317833 |
0.345 |
|
| 2020 |
Mullens W, Auricchio A, Martens P, Witte K, Cowie MR, Delgado V, Dickstein K, Linde C, Vernooy K, Leyva F, Bauersachs J, Israel CW, Lund L, Donal E, Boriani G, et al. Optimized Implementation of cardiac resynchronization therapy - a call for action for referral and optimization of care. European Journal of Heart Failure. PMID 33136300 DOI: 10.1002/ejhf.2046 |
0.349 |
|
| 2020 |
Straw S, McGinlay M, Relton SD, Koshy AO, Gierula J, Paton MF, Drozd M, Lowry JE, Cole C, Cubbon RM, Witte KK, Kearney MT. Effect of disease-modifying agents and their association with mortality in multi-morbid patients with heart failure with reduced ejection fraction. Esc Heart Failure. PMID 32924331 DOI: 10.1002/Ehf2.12978 |
0.475 |
|
| 2020 |
Caspi T, Straw S, Cheng C, Garnham JO, Scragg JL, Smith J, Koshy AO, Levelt E, Sukumar P, Gierula J, Beech DJ, Kearney MT, Cubbon RM, Wheatcroft SB, Witte KK, et al. Unique Transcriptome Signature Distinguishes Patients With Heart Failure With Myopathy. Journal of the American Heart Association. e017091. PMID 32892688 DOI: 10.1161/Jaha.120.017091 |
0.344 |
|
| 2020 |
Patel PA, Nadarajah R, Ali N, Gierula J, Witte KK. Cardiac contractility modulation for the treatment of heart failure with reduced ejection fraction. Heart Failure Reviews. PMID 32852661 DOI: 10.1007/S10741-020-10017-1 |
0.53 |
|
| 2020 |
Patel PA, Nadarajah R, Ali N, Tan F, Hammond C, Burnett N, Cole CA, Paton MF, Cubbon RM, Kearney MT, Gierula J, Witte KK. Long-term performance of left ventricular leads in cardiac resynchronisation therapy. Pacing and Clinical Electrophysiology : Pace. PMID 32779204 DOI: 10.1111/Pace.14034 |
0.464 |
|
| 2020 |
Straw S, Witte KK. Observational data during the COVID-19 pandemic: opportunity with uncertainty. Heart. 106: 1461-1462. PMID 32759292 DOI: 10.1136/Heartjnl-2020-317486 |
0.335 |
|
| 2020 |
Koshy AO, Gallivan ER, McGinlay M, Straw S, Drozd M, Toms AG, Gierula J, Cubbon RM, Kearney MT, Witte KK. Prioritizing symptom management in the treatment of chronic heart failure. Esc Heart Failure. PMID 32757363 DOI: 10.1002/Ehf2.12875 |
0.385 |
|
| 2020 |
Slater TA, Straw S, Drozd M, Kamalathasan S, Cowley A, Witte KK. Dying 'due to' or 'with' COVID-19: a cause of death analysis in hospitalised patients. Clinical Medicine (London, England). PMID 32753516 DOI: 10.7861/Clinmed.2020-0440 |
0.3 |
|
| 2020 |
Iqbal H, Straw S, Craven TP, Stirling K, Wheatcroft SB, Witte KK. Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus. Esc Heart Failure. PMID 32583975 DOI: 10.1002/Ehf2.12718 |
0.445 |
|
| 2020 |
Slater TA, Cupido B, Parry H, Drozd M, Blackburn ME, Hares D, Pepper CB, Birkitt L, Cullington D, Witte KK, Oliver J, English KM, Sengupta A. Implantable cardioverter-defibrillator therapy to reduce sudden cardiac death in adults with congenital heart disease: A registry study. Journal of Cardiovascular Electrophysiology. PMID 32583559 DOI: 10.1111/Jce.14633 |
0.453 |
|
| 2020 |
Ruf TF, Kreidel F, Tamm AR, Geyer M, Hahad O, Zirbs JC, Schwidtal BL, Beiras‐Fernandez A, Witte KK, Münzel T, Bardeleben RSv. Transcatheter indirect mitral annuloplasty induces annular and left atrial remodelling in secondary mitral regurgitation. Esc Heart Failure. 7: 1400-1408. PMID 32501644 DOI: 10.1002/Ehf2.12710 |
0.337 |
|
| 2020 |
Drozd M, Garland E, Walker AMN, Slater TA, Koshy A, Straw S, Gierula J, Paton M, Lowry J, Sapsford R, Witte KK, Kearney MT, Cubbon RM. Infection-Related Hospitalization in Heart Failure With Reduced Ejection Fraction: A Prospective Observational Cohort Study. Circulation. Heart Failure. 13: e006746. PMID 32354281 DOI: 10.1161/Circheartfailure.119.006746 |
0.474 |
|
| 2020 |
Gierula J, Lowry JE, Paton MF, Cole CA, Byrom R, Koshy AA, Chumun H, Kearney LC, Straw S, Bowen TS, Cubbon RM, Keenan AM, Stocken DD, Kearney MT, Witte KK. Personalised Rate-Response Programming Improves Exercise Tolerance After Six Months in People with Cardiac Implantable Electronic Devices and Heart Failure: A Phase II Study. Circulation. PMID 32299222 DOI: 10.1161/Circulationaha.119.045066 |
0.472 |
|
| 2020 |
Zakeri R, Morgan JM, Phillips P, Kitt S, Ng GA, McComb JM, Williams S, Wright DJ, Gill JS, Seed A, Witte KK, Cowie MR. Prevalence and prognostic significance of device-detected subclinical atrial fibrillation in patients with heart failure and reduced ejection fraction. International Journal of Cardiology. PMID 32169346 DOI: 10.1016/J.Ijcard.2020.03.008 |
0.479 |
|
| 2020 |
Zakeri R, Morgan JM, Phillips P, Kitt S, Ng GA, McComb JM, Williams S, Wright DJ, Gill JS, Seed A, Witte KK, Cowie MR. Impact of remote monitoring on clinical outcomes for patients with heart failure and atrial fibrillation: results from the REM-HF trial. European Journal of Heart Failure. PMID 31908129 DOI: 10.1002/Ejhf.1709 |
0.521 |
|
| 2020 |
McDiarmid AK, Swoboda PP, Erhayiem B, Bounford KA, Bijsterveld P, Tyndall K, Fent GJ, Garg P, Dobson LE, Musa TA, Foley JRJ, Witte KK, Kearney MT, Greenwood JP, Plein S. Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association. 9: e011521. PMID 31852424 DOI: 10.1161/Jaha.118.011521 |
0.379 |
|
| 2020 |
Paton MF, Landolina M, Billuart J, Field D, Sibley J, Witte K. Projected longevities of cardiac implantable defibrillators: a retrospective analysis over the period 2007-17 and the impact of technological factors in determining longevity. Europace. 22: 149-155. PMID 31407793 DOI: 10.1093/Europace/Euz222 |
0.326 |
|
| 2020 |
Koshy AO, Swoboda PPP, Gierula J, Witte KK. Cardiac magnetic resonance in patients with cardiac resynchronization therapy: is it time to scan with resynchronization on? Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 21: 554-562. PMID 30608530 DOI: 10.1093/europace/euy299 |
0.41 |
|
| 2020 |
Baldwin MM, Birch KM, Taylor BJ, Geirula J, Paton MF, Lowry JE, Kearney MT, Witte KK, Ferguson C. Feasibility And Effectiveness Of High-intensity Interval Training With Blood Flow Restriction In Heart Failure: 3259 Board #80 May 29 2:30 PM - 4:00 PM Medicine and Science in Sports and Exercise. 52: 890-890. DOI: 10.1249/01.Mss.0000685204.16599.De |
0.382 |
|
| 2020 |
Cole C, Lowry J, Paton M, Drozd M, Slater T, Witte K, Cubbon R, Kearney M, Gierula J. 98 Characteristics and long-term prognosis of patients with European society of cardiology defined heart failure with preserved ejection fraction presenting to secondary care: prospective cohort study Heart. 106. DOI: 10.1136/Heartjnl-2020-Bcs.98 |
0.51 |
|
| 2020 |
Gierula J, Lowry J, Paton MF, Byrom R, Koshy A, Charlotte C, Chumun HK, Kearney L, Sam S, Bowen TS, Cubbon R, Keenan A, Stocken D, Kearney M, Witte K. Personalised Rate-Response Programming Improves Long-Term Exercise Tolerance In People With Pacemaker Devices And Heart Failure Journal of the American College of Cardiology. 75: 318. DOI: 10.1016/S0735-1097(20)30945-1 |
0.438 |
|
| 2020 |
Paton MF, Gierula J, Lowry J, Byrom-Goulthorp R, Cubbon R, Kearney M, Witte K. Reprogramming To Prevent Progressive Pacemaker-Induced Remodelling Journal of the American College of Cardiology. 75: 314. DOI: 10.1016/S0735-1097(20)30941-4 |
0.499 |
|
| 2020 |
Reynolds M, Sawyer L, Jones FG, Witte KK, Yaghi S, Ziegler PD, Kaplon R, Rosemas S, Mittal S. Pcv27 Cost-Effectiveness Of Insertable Cardiac Monitors Versus Standard Of Care Or Short-To-Long-Term Ecg Monitoring To Identify Atrial Fibrillation After Cryptogenic Stroke Value in Health. 23. DOI: 10.1016/J.Jval.2020.04.132 |
0.31 |
|
| 2019 |
Witte K, Hasenfuss G, Kloppe A, Burkhoff D, Green M, Moss J, Peel A, Mealing S, Durand Zaleski I, Cowie MR. Cost-effectiveness of a cardiac contractility modulation device in heart failure with normal QRS duration. Esc Heart Failure. 6: 1178-1187. PMID 31997539 DOI: 10.1002/Ehf2.12526 |
0.509 |
|
| 2019 |
Jamil HA, Goldberg SL, Witte KK. Cardiac resynchronization therapy following Carillon® annuloplasty device for symptomatic heart failure and functional mitral regurgitation: a case report. European Heart Journal - Case Reports. 3: 1-5. PMID 31911977 DOI: 10.1093/Ehjcr/Ytz224 |
0.437 |
|
| 2019 |
Garnham JO, Roberts LD, Espino-Gonzalez E, Whitehead A, Swoboda PP, Koshy A, Gierula J, Paton MF, Cubbon RM, Kearney MT, Egginton S, Bowen TS, Witte KK. Chronic heart failure with diabetes mellitus is characterized by a severe skeletal muscle pathology. Journal of Cachexia, Sarcopenia and Muscle. PMID 31863644 DOI: 10.1002/Jcsm.12515 |
0.496 |
|
| 2019 |
Senni M, Wachter R, Witte KK, Straburzynska-Migaj E, Belohlavek J, Fonseca C, Mueller C, Lonn E, Chakrabarti A, Bao W, Noe A, Schwende H, Butylin D, Pascual-Figal D. Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study. European Journal of Heart Failure. PMID 31820537 DOI: 10.1002/Ejhf.1670 |
0.522 |
|
| 2019 |
Witte KK, Lipiecki J, Siminiak T, Meredith IT, Malkin CJ, Goldberg SL, Stark MA, von Bardeleben RS, Cremer PC, Jaber WA, Celermajer DS, Kaye DM, Sievert H. The REDUCE FMR Trial: A Randomized Sham-Controlled Study of Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation. Jacc. Heart Failure. PMID 31521683 DOI: 10.1016/J.Jchf.2019.06.011 |
0.357 |
|
| 2019 |
Garnham JO, Roberts LD, Caspi T, Al-Owais MM, Bullock M, Swoboda PP, Koshy A, Gierula J, Paton MF, Cubbon RM, Kearney MT, Bowen TS, Witte KK. Divergent skeletal muscle mitochondrial phenotype between male and female patients with chronic heart failure. Journal of Cachexia, Sarcopenia and Muscle. PMID 31430834 DOI: 10.1002/Jcsm.12488 |
0.397 |
|
| 2019 |
Hallén J, Maggioni AP, Lopez-De-Sa E, Turazza FM, Witte K, Erdmann E, Dahlström U, Ertl G, Nielsen OW, Sendon JL, Holbro T, Chen CW, Gimpelewicz C, Cowie MR. Reproducibility of in-hospital worsening heart failure event adjudication in the RELAX-AHF-EU trial. European Journal of Heart Failure. PMID 31359535 DOI: 10.1002/Ejhf.1574 |
0.455 |
|
| 2019 |
Paton MF, Gierula J, Jamil HA, Lowry JE, Byrom R, Gillott RG, Chumun H, Cubbon RM, Cairns DA, Stocken DD, Kearney MT, Witte KK. Optimising pacemaker therapy and medical therapy in pacemaker patients for heart failure: protocol for the OPT-PACE randomised controlled trial. Bmj Open. 9: e028613. PMID 31320354 DOI: 10.1136/Bmjopen-2018-028613 |
0.498 |
|
| 2019 |
Normand C, Linde C, Bogale N, Blomström-Lundqvist C, Auricchio A, Stellbrink C, Witte KK, Mullens W, Sticherling C, Marinskis G, Sciaraffia E, Papiashvili G, Iovev S, Dickstein K. Cardiac resynchronization therapy pacemaker or cardiac resynchronization therapy defibrillator : what determines the choice?-findings from the ESC CRT Survey II Europace. 21: 918-927. PMID 31157387 DOI: 10.1093/Europace/Euz002 |
0.495 |
|
| 2019 |
Wachter R, Senni M, Belohlavek J, Straburzynska-Migaj E, Witte KK, Kobalava Z, Fonseca C, Goncalvesova E, Cavusoglu Y, Fernandez A, Chaaban S, Bøhmer E, Pouleur AC, Mueller C, Tribouilloy C, et al. Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study. European Journal of Heart Failure. PMID 31134724 DOI: 10.1002/Ejhf.1498 |
0.511 |
|
| 2019 |
Koshy A, Witte K. Uses and potential for cardiac magnetic resonance imaging in patients with cardiac resynchronisation pacemakers Expert Review of Medical Devices. 16: 445-450. PMID 31096792 DOI: 10.1080/17434440.2019.1618706 |
0.348 |
|
| 2019 |
Straw S, Witte KK, Kearney MT. Heart failure: A preventable and treatable complication of type 2 diabetes. Journal of Diabetes. 11: 613-616. PMID 31037815 DOI: 10.1111/1753-0407.12930 |
0.428 |
|
| 2019 |
Paton MF, Witte KK. Heart failure and right ventricular pacing - how to avoid the need for cardiac resynchronization therapy. Expert Review of Medical Devices. 16: 35-43. PMID 30477355 DOI: 10.1080/17434440.2019.1552133 |
0.543 |
|
| 2019 |
Ferguson C, Davies MJ, Garnham JO, Gierula J, Paton MF, Rossiter HB, Witte KK. Dichotomy In The Mechanism Of Ramp-incremental Exercise Intolerance In Chronic Heart Failure Medicine & Science in Sports & Exercise. 51: 293. DOI: 10.1249/01.Mss.0000561385.40810.9D |
0.491 |
|
| 2019 |
Shyam-Sundar V, Swoboda P, Cubbon R, Greenwood J, Kearney M, Plein S, Witte K. 15 Improvement in diagnosis of ischaemic cardiomyopathy by cardiovascular magnetic resonance Heart. 105. DOI: 10.1136/Heartjnl-2019-Bcs.14 |
0.49 |
|
| 2019 |
Pascual-Figal D, Witte KK, Wachter R, Belohlavek J, Straburzynska-Migaj E, Fonseca C, Cavusoglu Y, Pouleur AC, Mueller C, Lonn E, Noe A, Schwende H, Bao W, Butylin D, Senni M. P1637Rehospitalisations during 26 weeks of follow up from initiation of sacubitril/valsartan after acute decompensated heart failure: An analysis of the TRANSITION study European Heart Journal. 40. DOI: 10.1093/Eurheartj/Ehz748.0396 |
0.48 |
|
| 2019 |
Koshy A, Gierula J, Paton M, Swoboda P, Toms A, Saunderson C, Shelley D, Plein D, Cubbon R, Kearney M, Witte K. P1236Revealing cardiac mechanics with CMR whilst CRT is active: the first step European Heart Journal. 40. DOI: 10.1093/Eurheartj/Ehz748.0194 |
0.348 |
|
| 2019 |
Wachter R, Pascual-Figal D, Belohlavek J, Straburzynska-Migaj E, Witte KK, Fonseca C, Cavusoglu Y, Pouleur AC, Goncalvesova E, Lonn E, Noe A, Schwende H, Bao W, Butylin D, Senni M. P773Initiation of sacubitril/valsartan and optimisation of evidence-based heart failure therapies after hospitalisation for acute decompensated heart failure: An analysis of the TRANSITION study European Heart Journal. 40. DOI: 10.1093/Eurheartj/Ehz747.0373 |
0.514 |
|
| 2019 |
Saunderson C, Paton MF, Gierula J, Brown LAE, Chew PG, Das A, Craven TP, Jain M, Levelt E, Dall"armellina E, Witte KK, Greenwood JP, Plein S, Swoboda PP. 492Prevalence and distribution of cardiac fibrosis in patients with atrioventricular block undergoing pacemaker implantation European Journal of Echocardiography. 20. DOI: 10.1093/Ehjci/Jez123.006 |
0.354 |
|
| 2019 |
Wachter R, Michele S, Witte K, Straburzynska-Migaj E, Belohlavek J, Fonseca C, Mueller C, Lonn E, Bao W, Noe A, Schwende H, Butylin D, Pascual-Figal D. Initiation of Sacubitril/Valsartan in Patients with De Novo Heart Failure with Reduced Ejection Fraction: An Analysis of the Transition Study Heart Lung and Circulation. 28. DOI: 10.1016/J.Hlc.2019.06.103 |
0.517 |
|
| 2019 |
Wachter R, Michele S, Witte K, Straburzynska-Migaj E, Belohlavek J, Fonseca C, Mueller C, Lonn E, Bao W, Noe A, Schwende H, Butylin D, Pascual-Figal D. In-Hospital Initiation of Sacubitril/Valsartan in Stabilised Patients with Heart Failure and Reduced Ejection Fraction Naïve to Renin-Angiotensin System Blocker: An Analysis of the Transition Study Heart Lung and Circulation. 28. DOI: 10.1016/J.Hlc.2019.06.102 |
0.491 |
|
| 2019 |
Goldberg SL, Levy WC, Witte KK, Lipiecki J, Siminiak T, Kaye DM, Malking CJ, Sievert H. Ejection Fraction Relative to Improvements in Mitral Regurgitation and Left Ventricular Remodeling after Implantation of Carillon Device Journal of Cardiac Failure. 25. DOI: 10.1016/J.Cardfail.2019.07.488 |
0.32 |
|
| 2019 |
Goldberg SL, Kapadia S, Witte KK, Kaye DM, Lipiecki J, Siminiak T, Malkin CJ, Sievert H. Impact of Carillon on COAPT Eligible/Non-Eligible Patients Journal of Cardiac Failure. 25. DOI: 10.1016/J.Cardfail.2019.07.486 |
0.335 |
|
| 2018 |
Straw S, Byrom R, Gierula J, Paton MF, Koshy A, Cubbon R, Drozd M, Kearney M, Witte KK. Predicting one-year mortality in heart failure using the 'Surprise Question': a prospective pilot study. European Journal of Heart Failure. 21: 227-234. PMID 30548129 DOI: 10.1002/Ejhf.1353 |
0.452 |
|
| 2018 |
Gierula J, Cubbon RM, Paton MF, Byrom R, Lowry JE, Winsor S, McGinley M, Sunley E, Pickles E, Kearney LC, Koshy A, Slater TA, Chumun H, Jamil HA, Bailey K, ... ... Witte KK, et al. Prospective evaluation and long term follow up of patients referred to secondary care based upon natriuretic peptide levels in primary care. European Heart Journal. Quality of Care & Clinical Outcomes. PMID 30452611 DOI: 10.1093/Ehjqcco/Qcy053 |
0.342 |
|
| 2018 |
Mercer BN, Koshy A, Drozd M, Walker AMN, Patel PA, Kearney L, Gierula J, Paton MF, Lowry JE, Kearney MT, Cubbon RM, Witte KK. Ischemic Heart Disease Modifies the Association of Atrial Fibrillation With Mortality in Heart Failure With Reduced Ejection Fraction. Journal of the American Heart Association. 7: e009770. PMID 30371286 DOI: 10.1161/Jaha.118.009770 |
0.453 |
|
| 2018 |
Walker AMN, Drozd M, Hall M, Patel PA, Paton M, Lowry J, Gierula J, Byrom R, Kearney L, Sapsford RJ, Witte KK, Kearney MT, Cubbon RM. Prevalence and Predictors of Sepsis Death in Patients With Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction. Journal of the American Heart Association. 7: e009684. PMID 30371261 DOI: 10.1161/Jaha.118.009684 |
0.489 |
|
| 2018 |
Cubbon RM, Lowry JE, Drozd M, Hall M, Gierula J, Paton MF, Byrom R, Kearney LC, Barth JH, Kearney MT, Witte KK. Vitamin D deficiency is an independent predictor of mortality in patients with chronic heart failure. European Journal of Nutrition. PMID 30121806 DOI: 10.1007/S00394-018-1806-Y |
0.44 |
|
| 2018 |
Patel PA, Ali N, Roy A, Pinder S, Cubbon RM, Kearney MT, Witte KK. Effects of Ivabradine on Hemodynamic and Functional Parameters in Left Ventricular Systolic Dysfunction: a Systematic Review and Meta-analysis. Journal of General Internal Medicine. PMID 30022413 DOI: 10.1007/S11606-018-4578-4 |
0.461 |
|
| 2018 |
Linde CM, Normand C, Bogale N, Auricchio A, Sterlinski M, Marinskis G, Sticherling C, Bulava A, Pérez ÓC, Maass AH, Witte KK, Rekvava R, Abdelali S, Dickstein K. Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II. European Journal of Heart Failure. 20: 1457-1468. PMID 29806208 DOI: 10.1002/Ejhf.1235 |
0.444 |
|
| 2018 |
Lowry JE, Fichtlscherer S, Witte KK. Therapeutic options for functional mitral regurgitation in chronic heart failure. Expert Review of Medical Devices. 15: 357-365. PMID 29724138 DOI: 10.1080/17434440.2018.1473032 |
0.544 |
|
| 2018 |
Tan C, Rossiter HB, Porszasz J, Bowen TS, Witte KK, Stringer WW, Casaburi R, Hansen JE. Reliability and Physiological Interpretation of Pulmonary Gas Exchange by "Circulatory Equivalents" in Chronic Heart Failure. Journal of the American Heart Association. 7. PMID 29588313 DOI: 10.1161/Jaha.117.008072 |
0.461 |
|
| 2018 |
Witte KK, Patel PA, Walker AMN, Schechter CB, Drozd M, Sengupta A, Byrom R, Kearney LC, Sapsford RJ, Kearney MT, Cubbon RM. Socioeconomic deprivation and mode-specific outcomes in patients with chronic heart failure. Heart (British Cardiac Society). PMID 29386325 DOI: 10.1136/Heartjnl-2017-312539 |
0.498 |
|
| 2018 |
Gierula J, Kearney MT, Witte KK. Devices in heart failure; diagnosis, detection and disease modification. British Medical Bulletin. 125: 91-102. PMID 29342243 DOI: 10.1093/Bmb/Ldx051 |
0.437 |
|
| 2018 |
Mercer BN, Koshy A, Drozd M, Walker A, Patel PA, Kearney L, Gierula J, Paton M, Lowry J, Kearney MT, Cubbon RM, Witte KK. 30Ischaemic aetiology modifies the association of atrial fibrillation with mortality in patients with heart failure with reduced ejection fraction Europace. 20. DOI: 10.1093/Europace/Euy199.011 |
0.522 |
|
| 2018 |
Senni M, Wachter R, Belohlavek J, Witte K, Strabuzynska-Migaj E, Kobalava Z, Fonseca C, Noe A, Butylin D, Schwende H, Pascual-Figal D. P6531Initiation of sacubitril/valsartan in hospitalized patients with HFrEF after hemodynamic stabilization: baseline characteristics of the TRANSITION study compared with TITRATION and PARADIGM-HF European Heart Journal. 39. DOI: 10.1093/Eurheartj/Ehy566.P6531 |
0.319 |
|
| 2018 |
Witte KK, Elkind MSV, Reynolds M, Tsintzos SI, Ziegler PD, Quiroz ME, Wolff C, Ricinog C, Sawyer L, Diamantopoulos A. P3157Economic evaluation of insertable cardiac monitors in detecting previously undiagnosed atrial fibrillation and subsequently moderating stoke risk in a high-risk population in the United Kingdom European Heart Journal. 39. DOI: 10.1093/Eurheartj/Ehy563.P3157 |
0.312 |
|
| 2017 |
Gierula J, Paton MF, Lowry JE, Jamil HA, Byrom R, Drozd M, Garnham JO, Cubbon RM, Cairns DA, Kearney MT, Witte KK. Rate-Response Programming Tailored to the Force-Frequency Relationship Improves Exercise Tolerance in Chronic Heart Failure. Jacc. Heart Failure. PMID 29226818 DOI: 10.1016/J.Jchf.2017.09.018 |
0.504 |
|
| 2017 |
Drozd M, Gierula J, Lowry JE, Paton MF, Joy E, Jamil HA, Cubbon RM, Kearney MT, Cairns DA, Witte KK. Cardiac resynchronization therapy outcomes in patients with chronic heart failure: cardiac resynchronization therapy with pacemaker versus cardiac resynchronization therapy with defibrillator. Journal of Cardiovascular Medicine (Hagerstown, Md.). 18: 962-967. PMID 29045311 DOI: 10.2459/Jcm.0000000000000584 |
0.495 |
|
| 2017 |
Foley JRJ, Swoboda PP, Fent GJ, Garg P, McDiarmid AK, Ripley DP, Erhayiem B, Musa TA, Dobson LE, Plein S, Witte KK, Greenwood JP. Quantitative deformation analysis differentiates ischaemic and non-ischaemic cardiomyopathy: sub-group analysis of the VINDICATE trial. European Heart Journal Cardiovascular Imaging. PMID 29029139 DOI: 10.1093/Ehjci/Jex235 |
0.45 |
|
| 2017 |
Witte KK, Drozd M, Walker AMN, Patel PA, Kearney JC, Chapman S, Sapsford RJ, Gierula J, Paton MF, Lowry J, Kearney MT, Cubbon RM. Mortality Reduction Associated With β-Adrenoceptor Inhibition in Chronic Heart Failure Is Greater in Patients With Diabetes. Diabetes Care. PMID 28982651 DOI: 10.2337/Dc17-1406 |
0.435 |
|
| 2017 |
Swoboda PP, McDiarmid AK, Erhayiem B, Ripley DP, Dobson LE, Garg P, Musa TA, Witte KK, Kearney MT, Barth JH, Ajjan R, Greenwood JP, Plein S. Diabetes Mellitus, Microalbuminuria, and Subclinical Cardiac Disease: Identification and Monitoring of Individuals at Risk of Heart Failure. Journal of the American Heart Association. 6. PMID 28716801 DOI: 10.1161/Jaha.117.005539 |
0.454 |
|
| 2017 |
Morgan JM, Kitt S, Gill J, McComb JM, Ng GA, Raftery J, Roderick P, Seed A, Williams SG, Witte KK, Wright DJ, Harris S, Cowie MR. Remote management of heart failure using implantable electronic devices. European Heart Journal. PMID 28575235 DOI: 10.1093/Eurheartj/Ehx227 |
0.464 |
|
| 2017 |
Kramer F, Sabbah HN, Januzzi JJ, Zannad F, Peter van Tintelen J, Schelbert EB, Kim RJ, Milting H, Vonk R, Neudeck B, Clark R, Witte K, Dinh W, Pieske B, Butler J, et al. Redefining the role of biomarkers in heart failure trials: expert consensus document. Heart Failure Reviews. PMID 28332132 DOI: 10.1007/S10741-017-9608-5 |
0.482 |
|
| 2017 |
Foley JR, Swoboda PP, Fent GJ, Garg P, Ripley DP, McDiarmid AK, Dobson LE, Musa TA, Plein S, Witte KK, Greenwood JP. 105 Differences in myocardial mechanics between ischaemic and non-ischaemic cardiomyopathy assessed by cmr: a sub-group analysis of the vindicate trial Heart. 103. DOI: 10.1136/Heartjnl-2017-311726.104 |
0.406 |
|
| 2017 |
Swoboda PP, McDiarmid AK, Erhayiem B, Ripley DP, Dobson LE, Garg P, Musa TA, Witte KK, Kearney MT, Barth JH, Ajjan R, Greenwood JP, Plein S. 029 Diabetes, microalbuminuria and subclinical cardiac disease: identification and monitoring of individuals at risk of heart failure Heart. 103. DOI: 10.1136/Heartjnl-2017-311399.29 |
0.367 |
|
| 2017 |
Witte KK, Cubbon RM, Lowry JE, Drozd M, Hall M, Gierula J, Paton MF, Byrom R, Kearney LC, Barth JH, Cairns DA, Kearney MT. P3240Vitamin D deficiency is an independent predictor of mortality in patients with chronic heart failure European Heart Journal. 38. DOI: 10.1093/Eurheartj/Ehx504.P3240 |
0.498 |
|
| 2016 |
Byrom R, Cairns DA, Witte KK. Reply: Potential Risk of Increased Risk of Falls Associated With High Doses of Vitamin D Treatment. Journal of the American College of Cardiology. 68: 1819-1820. PMID 27737753 DOI: 10.1016/J.Jacc.2016.07.759 |
0.339 |
|
| 2016 |
Gierula J, Paton MF, Byrom R, Cubbon RM, Kearney MT, Witte KK. Reply: The Paradox of Heart Failure and Atrial Fibrillation. Journal of the American College of Cardiology. 68: 1253. PMID 27609693 DOI: 10.1016/J.Jacc.2016.06.038 |
0.535 |
|
| 2016 |
Taylor C, Tsakirides C, Moxon J, Moxon JW, Dudfield M, Witte KK, Ingle L, Carroll S. Submaximal fitness and mortality risk reduction in coronary heart disease: a retrospective cohort study of community-based exercise rehabilitation. Bmj Open. 6: e011125. PMID 27363816 DOI: 10.1136/Bmjopen-2016-011125 |
0.399 |
|
| 2016 |
Walker AM, Patel PA, Rajwani A, Groves D, Denby C, Kearney L, Sapsford RJ, Witte KK, Kearney MT, Cubbon RM. Diabetes mellitus is associated with adverse structural and functional cardiac remodelling in chronic heart failure with reduced ejection fraction. Diabetes & Vascular Disease Research. PMID 27334485 DOI: 10.1177/1479164116653342 |
0.477 |
|
| 2016 |
Jamil HA, Gierula J, Paton MF, Byrom R, Lowry JE, Cubbon RM, Cairns DA, Kearney MT, Witte KK. Chronotropic Incompetence Does Not Limit Exercise Capacity in Chronic Heart Failure. Journal of the American College of Cardiology. 67: 1885-96. PMID 27102504 DOI: 10.1016/J.Jacc.2016.02.042 |
0.486 |
|
| 2016 |
Witte KK, Byrom R, Gierula J, Paton MF, Jamil HA, Lowry JE, Gillott RG, Barnes SA, Chumun H, Kearney LC, Greenwood JP, Plein S, Law GR, Pavitt S, Barth JH, et al. Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE Study. Journal of the American College of Cardiology. PMID 27058906 DOI: 10.1016/J.Jacc.2016.03.508 |
0.431 |
|
| 2016 |
Cubbon RM, Witte KK, Kearney LC, Gierula J, Byrom R, Paton M, Sengupta A, Patel PA, Mn Walker A, Cairns DA, Rajwani A, Hall AS, Sapsford RJ, Kearney MT. Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification. Heart (British Cardiac Society). PMID 26857212 DOI: 10.1136/Heartjnl-2015-308939 |
0.498 |
|
| 2016 |
Diamantopoulos A, Sawyer LM, Lip GY, Witte KK, Reynolds MR, Fauchier L, Thijs V, Brown B, Quiroz Angulo ME, Diener HC. Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke. International Journal of Stroke : Official Journal of the International Stroke Society. PMID 26763916 DOI: 10.1177/1747493015620803 |
0.307 |
|
| 2015 |
Cubbon RM, Ruff N, Groves D, Eleuteri A, Denby C, Kearney L, Ali N, Walker AM, Jamil H, Gierula J, Gale CP, Batin PD, Nolan J, Shah AM, Fox KA, ... ... Witte KK, et al. Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure. Heart (British Cardiac Society). PMID 26674986 DOI: 10.1136/Heartjnl-2015-308428 |
0.559 |
|
| 2015 |
Patel PA, Cubbon RM, Sapsford RJ, Gillott RG, Grant PJ, Witte KK, Kearney MT, Hall AS. An evaluation of 20year survival in patients with diabetes mellitus and acute myocardial infarction. International Journal of Cardiology. 203: 141-144. PMID 26512829 DOI: 10.1016/J.Ijcard.2015.10.094 |
0.316 |
|
| 2015 |
Jamil H, Gierula J, Byrom R, WInsor S, Sunley E, Kearney L, Houghton A, Bailey K, Cubbon R, Reynolds G, Pavitt S, David C, Julian B, Davis M, Sharples L, ... ... Witte K, et al. 47 Using Natriuretic Peptide Levels to Diagnose Heart Failure in Primary Care: An Evaluation of the 2010 United Kingdom National Institute of Clinical Excellence Guidelines on the Diagnosis of Chronic Heart Failure Heart. 101. DOI: 10.1136/Heartjnl-2015-308066.47 |
0.45 |
|
| 2015 |
Swoboda PP, Kidambi A, Gierula J, McDiarmid AK, Erhayiem B, Dobson LE, Musa TA, Ripley DP, Garg P, Witte KK, Greenwood JP, Plein S. The prognostic value of cardiovascular magnetic resonance in aborted sudden cardiac death Journal of Cardiovascular Magnetic Resonance. 1-2. DOI: 10.1093/Europace/Euu244.6 |
0.433 |
|
| 2014 |
Clancy JA, Mary DA, Witte KK, Greenwood JP, Deuchars SA, Deuchars J. Non-invasive vagus nerve stimulation in healthy humans reduces sympathetic nerve activity. Brain Stimulation. 7: 871-7. PMID 25164906 DOI: 10.1016/J.Brs.2014.07.031 |
0.317 |
|
| 2014 |
Morgan JM, Dimitrov BD, Gill J, Kitt S, Ng GA, McComb JM, Raftery J, Roderick P, Seed A, Williams SG, Witte KK, Wright DJ, Yao GL, Cowie MR. Rationale and study design of the REM-HF study: remote management of heart failure using implanted devices and formalized follow-up procedures. European Journal of Heart Failure. 16: 1039-45. PMID 25136791 DOI: 10.1002/Ejhf.149 |
0.451 |
|
| 2014 |
Witte KK, Byrom R. Micronutrients for chronic heart failure: end of the road or path to enlightenment? Jacc. Heart Failure. 2: 318-20. PMID 24952701 DOI: 10.1016/j.jchf.2014.04.001 |
0.401 |
|
| 2014 |
Cubbon RM, Woolston A, Adams B, Gale CP, Gilthorpe MS, Baxter PD, Kearney LC, Mercer B, Rajwani A, Batin PD, Kahn M, Sapsford RJ, Witte KK, Kearney MT. Prospective development and validation of a model to predict heart failure hospitalisation. Heart (British Cardiac Society). 100: 923-9. PMID 24647052 DOI: 10.1136/Heartjnl-2013-305294 |
0.463 |
|
| 2014 |
Gierula J, Witte KK. Response to (resynchronization) therapy in chronic heart failure: time for a different approach. European Journal of Heart Failure. 16: 117-8. PMID 24464864 DOI: 10.1002/ejhf.53 |
0.365 |
|
| 2014 |
Gierula J, Jamil HA, Byrom R, Joy ER, Cubbon RM, Kearney MT, Witte KK. Pacing-associated left ventricular dysfunction? Think reprogramming first! Heart (British Cardiac Society). 100: 765-9. PMID 24430095 DOI: 10.1136/Heartjnl-2013-304905 |
0.498 |
|
| 2014 |
Gierula J, Jamil HA, Witte KK. Septal pacing: still no clarity? Pacing and Clinical Electrophysiology : Pace. 37: 263-4. PMID 24325616 DOI: 10.1111/Pace.12311 |
0.308 |
|
| 2014 |
Witte KK. BLOCK-HF: a game changer or a step too far? Heart (British Cardiac Society). 100: 361-2. PMID 23842032 DOI: 10.1136/Heartjnl-2013-304334 |
0.531 |
|
| 2014 |
Witte KK. Taking any Route Possible to Achieve Cardiac Resynchronization Journal of Clinical and Experimental Cardiology. 2014. DOI: 10.4172/2155-9880.1000295 |
0.366 |
|
| 2014 |
Jamil H, Gierula J, Byrom R, Joy E, Kearney M, Witte K. 56 The Influence of Chronotropic Incompetence on Exercise Capacity in Chronic Heart Failure Heart. 100. DOI: 10.1136/Heartjnl-2014-306118.56 |
0.484 |
|
| 2014 |
Drozd M, Cubbon R, Gierula J, Jamil H, Crossfield S, Kearney M, Witte K. 54 Calcium Supplementation in Patients with Chronic Heart Failure: Is it Safe? Heart. 100. DOI: 10.1136/Heartjnl-2014-306118.54 |
0.415 |
|
| 2013 |
Gierula J, Cubbon RM, Jamil HA, Byrom R, Baxter PD, Pavitt S, Gilthorpe MS, Hewison J, Kearney MT, Witte KK. Cardiac resynchronization therapy in pacemaker-dependent patients with left ventricular dysfunction. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 15: 1609-14. PMID 23736807 DOI: 10.1093/europace/eut148 |
0.33 |
|
| 2013 |
Cubbon RM, Adams B, Rajwani A, Mercer BN, Patel PA, Gherardi G, Gale CP, Batin PD, Ajjan R, Kearney L, Wheatcroft SB, Sapsford RJ, Witte KK, Kearney MT. Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology. Diabetes & Vascular Disease Research. 10: 330-6. PMID 23349368 DOI: 10.1177/1479164112471064 |
0.456 |
|
| 2013 |
Witte KK. Cardiac resynchronisation therapy for chronic heart failure: predicting and measuring 'response'. Heart (British Cardiac Society). 99: 293-4. PMID 23349344 DOI: 10.1136/heartjnl-2012-303359 |
0.4 |
|
| 2013 |
Witte KK, Jamil HA. Thromboprophylaxis in heart failure patients with sinus rhythm: aspirin and warfarin lead to similar cardiovascular outcomes. Evidence-Based Medicine. 18: 69-70. PMID 22918068 DOI: 10.1136/eb-2012-100877 |
0.423 |
|
| 2013 |
Adams B, Cubbon RM, Witte KK, Rajwani A, Kearney LC, Gierula J, Sapsford RJ, Mercer BN, Gatenby VK, Gale CP, Gilthorpe MS, Kearney MT. 010 QUANTIFYING THE ASSOCIATION BETWEEN MORTALITY AND CHANGE IN ACE INHIBITOR AND β-BLOCKER DOSE IN PATIENTS WITH CHRONIC HEART FAILURE: A PROSPECTIVE COHORT STUDY Heart. 99. DOI: 10.1136/Heartjnl-2013-304019.10 |
0.44 |
|
| 2012 |
Bowen TS, Cannon DT, Begg G, Baliga V, Witte KK, Rossiter HB. A novel cardiopulmonary exercise test protocol and criterion to determine maximal oxygen uptake in chronic heart failure. Journal of Applied Physiology (Bethesda, Md. : 1985). 113: 451-8. PMID 22653993 DOI: 10.1152/Japplphysiol.01416.2011 |
0.411 |
|
| 2012 |
McKenna C, Walker S, Lorgelly P, Fenwick E, Burch J, Suekarran S, Bakhai A, Witte K, Harden M, Wright K, Woolacott N, Palmer S. Cost-effectiveness of aldosterone antagonists for the treatment of post-myocardial infarction heart failure Value in Health. 15: 420-428. PMID 22583451 DOI: 10.1016/J.Jval.2012.01.004 |
0.377 |
|
| 2012 |
Mak S, Witte KK, Al-Hesayen A, Granton JJ, Parker JD. Cardiac sympathetic activation in patients with pulmonary arterial hypertension. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 302: R1153-7. PMID 22422664 DOI: 10.1152/Ajpregu.00652.2011 |
0.412 |
|
| 2012 |
Bowen TS, Cannon DT, Murgatroyd SR, Birch KM, Witte KK, Rossiter HB. The intramuscular contribution to the slow oxygen uptake kinetics during exercise in chronic heart failure is related to the severity of the condition. Journal of Applied Physiology (Bethesda, Md. : 1985). 112: 378-87. PMID 22033530 DOI: 10.1152/Japplphysiol.00779.2011 |
0.41 |
|
| 2012 |
Al-Najjar Y, Witte KK, Clark AL. Chronotropic incompetence and survival in chronic heart failure. International Journal of Cardiology. 157: 48-52. PMID 21185094 DOI: 10.1016/J.Ijcard.2010.11.018 |
0.463 |
|
| 2011 |
Bogale N, Witte K, Priori S, Cleland J, Auricchio A, Gadler F, Gitt A, Limbourg T, Linde C, Dickstein K, Fruhwald F, Strohmer B, Goethals M, Vijgen J, Trochu JN, et al. The European Cardiac Resynchronization Therapy Survey: Comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades European Journal of Heart Failure. 13: 974-983. PMID 21771823 DOI: 10.1093/Eurjhf/Hfr085 |
0.502 |
|
| 2011 |
Cubbon RM, Gale CP, Kearney LC, Schechter CB, Brooksby WP, Nolan J, Fox KA, Rajwani A, Baig W, Groves D, Barlow P, Fisher AC, Batin PD, Kahn MB, Zaman AG, ... ... Witte KK, et al. Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras. Circulation. Heart Failure. 4: 396-403. PMID 21562056 DOI: 10.1161/Circheartfailure.110.959882 |
0.515 |
|
| 2011 |
Witte KK, Clark AL. NYHA class I heart failure is not 'mild'. International Journal of Cardiology. 146: 128-9. PMID 20970201 DOI: 10.1016/J.Ijcard.2010.10.006 |
0.543 |
|
| 2011 |
Cannon DT, Bowen TS, Murgatroyd SR, Witte KK, Koga S, Rossiter HB. Inferences from Skeletal Muscle Deoxygenation Kinetics during Constant and Incremental Exercise in Heart Failure Medicine & Science in Sports & Exercise. 43: 116. DOI: 10.1249/01.Mss.0000403019.48163.0F |
0.438 |
|
| 2011 |
Bowen TS, Cannon DT, Murgatroyd SR, Witte KK, Rossiter HB. 97 Increasing skeletal muscle oxygenation by prior moderate-intensity exercise increases aerobic energy provision in chronic heart failure Heart. 97: A56-A56. DOI: 10.1136/Heartjnl-2011-300198.97 |
0.37 |
|
| 2011 |
Bowen TS, Cannon DT, Begg G, Baliga V, Witte KK, Rossiter HB. 96 A test to confirm maximal oxygen uptake in chronic heart failure patients without the need for secondary criteria Heart. 97: A56-A56. DOI: 10.1136/Heartjnl-2011-300198.96 |
0.397 |
|
| 2011 |
Begg GA, Gierula J, Waldron ZL, Witte KK. 154 Patients receiving standard pacemaker generator replacements frequently have impaired left ventricular function and exercise intolerance, related to the percentage of right ventricular pacing Heart. 97. DOI: 10.1136/Heartjnl-2011-300198.154 |
0.469 |
|
| 2010 |
Begg GA, Witte KK. Closing the door after the horse has bolted: device therapy in patients with end-stage heart failure. Journal of Cardiac Failure. 16: 938-9. PMID 21111982 DOI: 10.1016/j.cardfail.2010.08.013 |
0.381 |
|
| 2010 |
Shelton RJ, Ingle L, Rigby AS, Witte KK, Cleland JG, Clark AL. Cardiac output does not limit submaximal exercise capacity in patients with chronic heart failure. European Journal of Heart Failure. 12: 983-9. PMID 20525704 DOI: 10.1093/Eurjhf/Hfq086 |
0.459 |
|
| 2010 |
McKenna C, Burch J, Suekarran S, Walker S, Bakhai A, Witte K, Harden M, Wright K, Woolacott N, Lorgelly P, Fenwick L, Palmer S. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure Health Technology Assessment. 14: i-161. DOI: 10.3310/Hta14240 |
0.412 |
|
| 2010 |
Cannon DT, Bowen TS, Witte KK, Rossiter HB. Dissociating the Attainment of Maximal Oxygen Uptake from Symptom Limitation During Exercise in Heart Failure Medicine & Science in Sports & Exercise. 42: 74. DOI: 10.1249/01.Mss.0000385549.05606.19 |
0.449 |
|
| 2010 |
Bowen TS, Cannon DT, Murgatroyd SR, Witte KK, Rossiter HB. Moderate-Intensity Exercise Increases Subsequent Muscle Oxygenation and Speeds VO2 Kinetics in Chronic Heart Failure Medicine & Science in Sports & Exercise. 42: 23. DOI: 10.1249/01.Mss.0000384514.97046.B0 |
0.441 |
|
| 2009 |
Roberts AW, Clark AL, Witte KK. Review article: Left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease--do we need to screen our patients? Diabetes & Vascular Disease Research. 6: 153-63. PMID 20368207 DOI: 10.1177/1479164109338774 |
0.478 |
|
| 2009 |
Witte KK, Clark AL. Marine polyunsaturated fatty acids in heart failure. Are the theoretical benefits matched by the clinical data? Polskie Archiwum Medycyny Wewnä™Trznej. 119: 162-9. PMID 19514646 |
0.325 |
|
| 2009 |
Cubbon RM, Witte KK. Cardiac resynchronisation therapy for chronic heart failure and conduction delay. Bmj (Clinical Research Ed.). 338: b1265. PMID 19401320 DOI: 10.1136/bmj.b1265 |
0.425 |
|
| 2009 |
Ingle L, Isted A, Witte KK, Cleland JG, Clark AL. Impact of different diagnostic criteria on the prevalence and prognostic significance of exertional oscillatory ventilation in patients with chronic heart failure. European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups On Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. 16: 451-6. PMID 19369874 DOI: 10.1097/Hjr.0B013E32832A4F54 |
0.508 |
|
| 2009 |
Carasso S, Rakowski H, Witte KK, Smith P, Carasso D, Garceau P, Sasson Z, Parker JD. Left ventricular strain patterns in dilated cardiomyopathy predict response to cardiac resynchronization therapy: timing is not everything. Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. 22: 242-50. PMID 19168325 DOI: 10.1016/J.Echo.2008.12.003 |
0.414 |
|
| 2009 |
Witte KK, Clark AL. Chronotropic incompetence does not contribute to submaximal exercise limitation in patients with chronic heart failure. International Journal of Cardiology. 134: 342-4. PMID 18571253 DOI: 10.1016/J.Ijcard.2008.02.014 |
0.524 |
|
| 2008 |
Witte KK, Clark AL. Dyspnoea versus fatigue: additional prognostic information from symptoms in chronic heart failure? European Journal of Heart Failure. 10: 1224-8. PMID 18996048 DOI: 10.1016/j.ejheart.2008.09.017 |
0.345 |
|
| 2008 |
Witte KK, Pepper CB, Thomson JD, English KM. Letter by Witte et al regarding article, "implantable cardioverter-defibrillators in tetralogy of fallot". Circulation. 118: e99; author reply e1. PMID 18663095 DOI: 10.1161/Circulationaha.108.771352 |
0.406 |
|
| 2008 |
Witte KK, Clark AL. Carvedilol in the treatment of elderly patients with chronic heart failure. Clinical Interventions in Aging. 3: 55-70. PMID 18488879 |
0.424 |
|
| 2008 |
Witte KK, Sasson Z, Persaud JA, Jolliffe R, Wald RW, Parker JD. Biventricular pacing: impact on exercise-induced increases in mitral insufficiency in patients with chronic heart failure. The Canadian Journal of Cardiology. 24: 379-84. PMID 18464943 DOI: 10.1016/S0828-282X(08)70601-9 |
0.433 |
|
| 2008 |
Witte KK, Pepper CB, Cowan JC, Thomson JD, English KM, Blackburn ME. Implantable cardioverter-defibrillator therapy in adult patients with tetralogy of Fallot. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 10: 926-30. PMID 18442962 DOI: 10.1093/Europace/Eun108 |
0.426 |
|
| 2008 |
Witte KK, Notarius CF, Ivanov J, Floras JS. Muscle sympathetic nerve activity and ventilation during exercise in subjects with and without chronic heart failure. The Canadian Journal of Cardiology. 24: 275-8. PMID 18401467 |
0.319 |
|
| 2008 |
Ingle L, Witte KK, Cleland JG, Clark AL. Combining the ventilatory response to exercise and peak oxygen consumption is no better than peak oxygen consumption alone in predicting mortality in chronic heart failure. European Journal of Heart Failure. 10: 85-8. PMID 18068430 DOI: 10.1016/J.Ejheart.2007.10.010 |
0.472 |
|
| 2008 |
Witte KK, Ford SJ, Preston T, Parker JD, Clark AL. Fibrinogen synthesis is increased in cachectic patients with chronic heart failure. International Journal of Cardiology. 129: 363-7. PMID 18022259 DOI: 10.1016/j.ijcard.2007.07.119 |
0.336 |
|
| 2008 |
Ingle L, Witte KK, Cleland JG, Clark AL. The prognostic value of cardiopulmonary exercise testing with a peak respiratory exchange ratio of <1.0 in patients with chronic heart failure. International Journal of Cardiology. 127: 88-92. PMID 17698222 DOI: 10.1016/J.Ijcard.2007.04.075 |
0.352 |
|
| 2007 |
Cleland JG, Coletta AP, Abdellah AT, Witte KK, Hobson N, Clark AL. Clinical trials update from Heart Rhythm 2007 and Heart Failure 2007: CARISMA, PREPARE, DAVID II, SAVE-PACE, PROTECT and AREA-IN-CHF. European Journal of Heart Failure. 9: 850-3. PMID 17644412 DOI: 10.1016/J.Ejheart.2007.07.003 |
0.49 |
|
| 2007 |
Witte KK, Levy WC, Lindsay KA, Clark AL. Biomechanical efficiency is impaired in patients with chronic heart failure. European Journal of Heart Failure. 9: 834-8. PMID 17569581 DOI: 10.1016/J.Ejheart.2007.05.004 |
0.388 |
|
| 2007 |
Witte KK, Clark AL. Why does chronic heart failure cause breathlessness and fatigue? Progress in Cardiovascular Diseases. 49: 366-84. PMID 17329182 DOI: 10.1016/J.Pcad.2006.10.003 |
0.515 |
|
| 2007 |
Witte KK, Parker JD. Biventricular pacing in patients with right ventricular pacing-induced heart failure. Journal of Cardiovascular Electrophysiology. 18: E12. PMID 17212593 DOI: 10.1111/J.1540-8167.2006.00700.X |
0.542 |
|
| 2007 |
de Silva R, Nikitin NP, Witte KK, Rigby AS, Loh H, Nicholson A, Bhandari S, Clark AL, Cleland JG. Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure. European Journal of Heart Failure. 9: 415-23. PMID 17174600 DOI: 10.1016/j.ejheart.2006.10.003 |
0.336 |
|
| 2006 |
Cleland JGF, Coletta A, Witte K. Practical Applications of Intravenous Diuretic Therapy in Decompensated Heart Failure The American Journal of Medicine. 119: 26-36. PMID 17113397 DOI: 10.1016/J.Amjmed.2006.09.014 |
0.481 |
|
| 2006 |
Thackray SD, Ghosh JM, Wright GA, Witte KK, Nikitin NP, Kaye GC, Clark AL, Tweddel A, Cleland JG. The effect of altering heart rate on ventricular function in patients with heart failure treated with beta-blockers. American Heart Journal. 152: 713.e9-13. PMID 16996845 DOI: 10.1016/j.ahj.2006.07.007 |
0.426 |
|
| 2006 |
Witte KK, Clark AL. Resting left ventricular function, however measured, is poorly related to exercise capacity in chronic heart failure. The American Journal of Cardiology. 98: 709-10. PMID 16923470 DOI: 10.1016/J.Amjcard.2006.05.002 |
0.506 |
|
| 2006 |
Witte KK, Clark AL. Chronotropic incompetence in heart failure. Journal of the American College of Cardiology. 48: 595; author reply 59. PMID 16875998 DOI: 10.1016/J.Jacc.2006.05.014 |
0.542 |
|
| 2006 |
de Silva R, Rigby AS, Witte KK, Nikitin NP, Tin L, Goode K, Bhandari S, Clark AL, Cleland JG. Anemia, renal dysfunction, and their interaction in patients with chronic heart failure. The American Journal of Cardiology. 98: 391-8. PMID 16860030 DOI: 10.1016/j.amjcard.2006.01.107 |
0.364 |
|
| 2006 |
Witte KK, Clark AL. Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives. Heart Failure Reviews. 11: 65-74. PMID 16819579 DOI: 10.1007/S10741-006-9194-4 |
0.46 |
|
| 2006 |
Witte KK, Parker JD. Identification of lateral cardiac veins for cardiac resynchronization therapy. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups On Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 8: 506-7. PMID 16798764 DOI: 10.1093/Europace/Eul068 |
0.45 |
|
| 2006 |
Witte KK, Pipes RR, Nanthakumar K, Parker JD. Biventricular pacemaker upgrade in previously paced heart failure patients--improvements in ventricular dyssynchrony. Journal of Cardiac Failure. 12: 199-204. PMID 16624685 DOI: 10.1016/j.cardfail.2005.12.003 |
0.498 |
|
| 2006 |
Witte KK, Nikitin NP, Cleland JG, Clark AL. Excessive breathlessness in patients with diastolic heart failure. Heart (British Cardiac Society). 92: 1425-9. PMID 16621875 DOI: 10.1136/Hrt.2005.081521 |
0.467 |
|
| 2006 |
de Silva R, Nikitin NP, Witte KK, Rigby AS, Goode K, Bhandari S, Clark AL, Cleland JG. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. European Heart Journal. 27: 569-81. PMID 16364971 DOI: 10.1093/eurheartj/ehi696 |
0.408 |
|
| 2006 |
Thackray SDR, Witte K, Ghosh J, Nikitin N, Anderson A, Rigby A, Goode K, Clark AL, Cleland JGF. N-terminal brain natriuretic peptide as a screening tool for heart failure in the pacemaker population. European Heart Journal. 27: 447-453. PMID 16299020 DOI: 10.1093/Eurheartj/Ehi657 |
0.518 |
|
| 2006 |
Witte KK, Cleland JG, Clark AL. Chronic heart failure, chronotropic incompetence, and the effects of beta blockade. Heart (British Cardiac Society). 92: 481-6. PMID 16159968 DOI: 10.1136/Hrt.2004.058073 |
0.53 |
|
| 2005 |
Witte KK, Clark AL. Chronic heart failure and multiple micronutrient supplementation: realistic hope or idealistic conjecture? Heart Failure Monitor. 4: 123-9. PMID 16234899 |
0.408 |
|
| 2005 |
Cleland JG, Coletta AP, Lammiman M, Witte KK, Loh H, Nasir M, Clark AL. Clinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE. European Journal of Heart Failure. 7: 1070-5. PMID 16227146 DOI: 10.1016/J.Ejheart.2005.09.006 |
0.549 |
|
| 2005 |
Banerjee P, Clark A, Witte K, Crowe L, Caulfield B. Electrical stimulation of unloaded muscles causes cardiovascular exercise by increasing oxygen demand. European Journal of Preventive Cardiology. 12: 503-508. PMID 16210939 DOI: 10.1097/01.Hjr.0000169188.84184.23 |
0.331 |
|
| 2005 |
Witte KK, Nikitin NP, Parker AC, von Haehling S, Volk HD, Anker SD, Clark AL, Cleland JG. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. European Heart Journal. 26: 2238-44. PMID 16081469 DOI: 10.1093/eurheartj/ehi442 |
0.398 |
|
| 2005 |
Witte KK, Kelly SJ, Parker JD, Nanthakumar K. Deployment of left ventricular lead from the ipsilateral side of central vein obstruction. Journal of Interventional Cardiac Electrophysiology : An International Journal of Arrhythmias and Pacing. 13: 47-50. PMID 15976978 DOI: 10.1007/s10840-005-0786-z |
0.381 |
|
| 2005 |
Witte KK, Thackray S, Nikitin NP, Cleland JG, Clark AL. The effects of long-term beta-blockade on the ventilatory responses to exercise in chronic heart failure. European Journal of Heart Failure. 7: 612-7. PMID 15921802 DOI: 10.1016/j.ejheart.2004.05.006 |
0.329 |
|
| 2005 |
Olsson LG, Swedberg K, Clark AL, Witte KK, Cleland JG. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. European Heart Journal. 26: 778-93. PMID 15774495 DOI: 10.1093/Eurheartj/Ehi162 |
0.432 |
|
| 2005 |
Witte KK, Clark AL. Beta-blockers and inspiratory pulmonary function in chronic heart failure. Journal of Cardiac Failure. 11: 112-6. PMID 15732030 DOI: 10.1016/j.cardfail.2004.07.007 |
0.324 |
|
| 2005 |
Witte KK, Clark AL. Cycle exercise causes a lower ventilatory response to exercise in chronic heart failure. Heart (British Cardiac Society). 91: 225-6. PMID 15657241 DOI: 10.1136/hrt.2003.026567 |
0.324 |
|
| 2005 |
Witte KK, Clark AL. Heart failure improvement from a supplement containing copper: reply European Heart Journal. 27: 117-118. DOI: 10.1093/Eurheartj/Ehi635 |
0.494 |
|
| 2004 |
Witte KK, Clark AL. The effect of aspirin on the ventilatory response to exercise in chronic heart failure. European Journal of Heart Failure. 6: 745-8. PMID 15542410 DOI: 10.1016/j.ejheart.2003.11.008 |
0.389 |
|
| 2004 |
Witte KK, Nikitin NP, De Silva R, Cleland JG, Clark AL. Exercise capacity and cardiac function assessed by tissue Doppler imaging in chronic heart failure. Heart (British Cardiac Society). 90: 1144-50. PMID 15367509 DOI: 10.1136/hrt.2003.025684 |
0.39 |
|
| 2004 |
Witte KK, Clark AL. Fish oils--adjuvant therapy in chronic heart failure? European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups On Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology. 11: 267-74. PMID 15292759 DOI: 10.1097/01.hjr.0000136728.27524.f5 |
0.312 |
|
| 2004 |
Witte KK, Desilva R, Chattopadhyay S, Ghosh J, Cleland JG, Clark AL. Are hematinic deficiencies the cause of anemia in chronic heart failure? American Heart Journal. 147: 924-30. PMID 15131553 DOI: 10.1016/j.ahj.2003.11.007 |
0.445 |
|
| 2004 |
Witte KK, Morice A, Cleland JG, Clark AL. The reversibility of increased airways resistance in chronic heart failure measured by impulse oscillometry. Journal of Cardiac Failure. 10: 149-54. PMID 15101027 |
0.343 |
|
| 2003 |
Witte KK, Thackray SD, Nikitin NP, Cleland JG, Clark AL. The effects of alpha and beta blockade on ventilatory responses to exercise in chronic heart failure. Heart (British Cardiac Society). 89: 1169-73. PMID 12975409 |
0.312 |
|
| 2003 |
Thackray SD, Witte KK, Nikitin NP, Clark AL, Kaye GC, Cleland JG. The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional pacemaker population. European Heart Journal. 24: 1143-52. PMID 12804929 |
0.397 |
|
| 2003 |
Witte KK, Thackray SD, Nikitin NP, Cleland JG, Clark AL. Pattern of ventilation during exercise in chronic heart failure. Heart (British Cardiac Society). 89: 610-4. PMID 12748213 |
0.38 |
|
| 2002 |
Nikitin NP, Witte KK, Clark AL, Cleland JG. Color tissue Doppler-derived long-axis left ventricular function in heart failure with preserved global systolic function. The American Journal of Cardiology. 90: 1174-7. PMID 12423730 |
0.362 |
|
| 2002 |
Witte KK, Morice A, Clark AL, Cleland JG. Airway resistance in chronic heart failure measured by impulse oscillometry. Journal of Cardiac Failure. 8: 225-31. PMID 12397570 |
0.344 |
|
| 2002 |
Thackray SD, Witte KK, Nikitin NP, Cleland JG. The prevalence of heart failure in the permanently paced population and the utility of BNP as a screening tool Journal of the American College of Cardiology. 39: 160. DOI: 10.1016/S0735-1097(02)80707-0 |
0.435 |
|
| 2002 |
Nikitin NP, Witte KK, Thackray SD, Alamgir MF, Goodge LJ, Clark AL, Cleland JG. Functional mitral regurgitation in patients with chronic heart failure: relationship to left ventricular and left atrial structural and functional parameters Journal of the American College of Cardiology. 39: 130. DOI: 10.1016/S0735-1097(02)80568-X |
0.485 |
|
| 2001 |
Witte KK, Clark AL, Cleland JG. Chronic heart failure and micronutrients. Journal of the American College of Cardiology. 37: 1765-74. PMID 11401109 |
0.411 |
|
| 2001 |
Thackray SD, Witte KK, Khand A, Dunn A, Clark AL, Cleland JG. Clinical trials update: highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT, COPERNICUS, MERIT, CIBIS-II, BEST, AMIOVIRT, V-MAC, BREATHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myoblast transfer for heart failure. European Journal of Heart Failure. 3: 117-24. PMID 11163746 |
0.355 |
|
| 2001 |
Cleland JGF, Louis A, Witte K. Pharmacoeconomics in heart failure : impact of drug and non-drug based treatment European Heart Journal. 3. DOI: 10.1016/S0195-668X(01)80005-1 |
0.507 |
|
| 2000 |
Witte K, Thackray S, Clark AL, Cooklin M, Cleland JGF. Clinical trials update: IMPROVEMENT-HF, COPERNICUS, MUSTIC, ASPECT-II, APRICOT and HEART. European Journal of Heart Failure. 2: 455-460. PMID 11113724 DOI: 10.1016/S1388-9842(00)00127-6 |
0.513 |
|
| 2000 |
Witte K. The Heart Failure Journal Club: a review of publications on heart failure in Heart European Journal of Heart Failure : Journal of the Working Group On Heart Failure of the European Society of Cardiology. 2: 213-222. PMID 10960268 DOI: 10.1016/S1388-9842(00)00079-9 |
0.491 |
|
| 2000 |
Thackray S, Witte K, Clark AL, Cleland JGF. Clinical trials update: OPTIME‐CHF, PRAISE‐2, ALL‐HAT European Journal of Heart Failure. 2: 209-212. PMID 10856736 DOI: 10.1016/S1388-9842(00)00080-5 |
0.522 |
|
| 2000 |
Witte K, Thackray S, Banerjee T, Clark AL, Cleland JGF. Update of ELITE-II, BEST, CHAMP, and IMPRESS clinical trials in heart failure. European Journal of Heart Failure. 2: 107-112. PMID 10742710 DOI: 10.1016/S1388-9842(00)00053-2 |
0.462 |
|
| Show low-probability matches. |